9 Meters Biopharma Inc. (NMTR): Is this the Most Sought-After Stock Today?

Let’s start up with the current stock price of 9 Meters Biopharma Inc. (NMTR), which is $0.70 to be very precise. The Stock rose vividly during the last session to $0.716 after opening rate of $0.6855 while the lowest price it went was recorded $0.68 before closing at $0.69.Recently in News on February 9, 2022, 9 Meters Biopharma to Present at the 2022 BIO CEO & Investor Conference. 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases announced today that John Temperato, President & Chief Executive Officer of 9 Meters Biopharma, Inc., will deliver a virtual presentation as part of the 2022 BIO CEO & Investor Conference taking place February 14-17, 2022. You can read further details here

9 Meters Biopharma Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.0300 on 01/04/22, with the lowest value was $0.6500 for the same time period, recorded on 02/07/22.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


9 Meters Biopharma Inc. (NMTR) full year performance was -64.72%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, 9 Meters Biopharma Inc. shares are logging -69.24% during the 52-week period from high price, and 6.94% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.65 and $2.26.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2127118 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the 9 Meters Biopharma Inc. (NMTR) recorded performance in the market was -28.98%, having the revenues showcasing -38.49% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 175.12M, as it employees total of 12 workers.

The Analysts eye on 9 Meters Biopharma Inc. (NMTR)

During the last month, 0 analysts gave the 9 Meters Biopharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.0389, with a change in the price was noted -0.54. In a similar fashion, 9 Meters Biopharma Inc. posted a movement of -43.94% for the period of last 100 days, recording 1,666,562 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NMTR is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of 9 Meters Biopharma Inc. (NMTR)

Raw Stochastic average of 9 Meters Biopharma Inc. in the period of last 50 days is set at 11.28%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 20.59%. In the last 20 days, the company’s Stochastic %K was 16.20% and its Stochastic %D was recorded 13.47%.

Considering, the past performance of 9 Meters Biopharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -28.98%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -33.16%, alongside a downfall of -64.72% for the period of the last 12 months. The shares increased approximately by 0.74% in the 7-day charts and went up by -18.22% in the period of the last 30 days. Common stock shares were lifted by -38.49% during last recorded quarter.

Leave a Reply

Your email address will not be published. Required fields are marked *